Fate Therapeutics (FATE)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
1.1700 -0.0800 (-6.40%) 04/29/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 1.1800 +0.0100 (+0.85%) 19:56 ET
for Tue, Apr 29th, 2025
Results
download Want to compare other data? Select Fields| Symbol | FATE | ADCT | EPRX | ||
| Company | Fate Therapeutics | Adc Therapeutics Sa | Eupraxia Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 1.2500 | 1.4300 | 4.09 | ||
| High | 1.2700 | 1.4600 | 4.09 | ||
| Low | 1.1500 | 1.3900 | 3.90 | ||
| Last | 1.1700 | 1.4200 | 3.93 | ||
| Change | -0.0800 | -0.0400 | -0.06 | ||
| % Change | -6.40% | -2.74% | -1.50% | ||
| Volume | 1,372,900 | 189,000 | 11,200 | ||
| 20-Day Average Volume | 2,494,560 | 324,060 | 11,530 | ||
| Previous Close | 1.2500 | 1.4600 | 3.99 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 1.0452 | 1.2510 | 3.37 | ||
| 20-Day Raw Stochastic | 61.39% | 82.22% | 88.65% | ||
| 20-Day Relative Strength | 52.68% | 50.02% | 59.30% | ||
| Weighted Alpha | -76.04 | -61.68 | +43.56 | ||
| Today's Opinion | 56% Sell | 88% Sell | 72% Buy | ||
| Previous Opinion | 56% Sell | 88% Sell | 72% Buy | ||
| Last Month's Opinion | 100% Sell | 88% Sell | 64% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -14.60% since 04/22/25 | +15.45% since 04/22/25 | +2.08% since 04/22/25 | ||
| Low | 1.1500 on 04/29/25 | 1.2700 on 04/23/25 | 3.75 on 04/28/25 | ||
| High | 1.4900 on 04/23/25 | 1.5000 on 04/28/25 | 4.09 on 04/29/25 | ||
| 1-Month | |||||
| %Chg | +37.76% since 03/28/25 | -4.70% since 03/28/25 | +16.27% since 03/28/25 | ||
| Low | 0.6611 on 04/04/25 | 1.0500 on 04/09/25 | 2.68 on 04/07/25 | ||
| High | 1.4900 on 04/23/25 | 1.5000 on 04/28/25 | 4.09 on 04/29/25 | ||
| 3-Month | |||||
| %Chg | -10.69% since 01/29/25 | -13.94% since 01/29/25 | +37.41% since 01/29/25 | ||
| Low | 0.6611 on 04/04/25 | 1.0500 on 04/09/25 | 2.68 on 04/07/25 | ||
| High | 1.8100 on 02/19/25 | 1.9100 on 03/12/25 | 4.48 on 02/27/25 | ||
| 6-Month | |||||
| %Chg | -56.99% since 10/29/24 | -52.82% since 10/29/24 | +61.73% since 10/29/24 | ||
| Low | 0.6611 on 04/04/25 | 1.0500 on 04/09/25 | 2.47 on 10/30/24 | ||
| High | 3.5000 on 11/18/24 | 3.4900 on 12/10/24 | 4.48 on 02/27/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 143,255 | 144,800 | 143,037 | ||
| Shares Outstanding, K | 114,604 | 99,178 | 35,849 | ||
| Annual Sales | 13,630,000 | 70,840,000 | 0 | ||
| Annual Net Income | -186,260,000 | -157,850,000 | -25,500,000 | ||
| Last Quarter Sales | 1,860,000 | 16,910,000 | 0 | ||
| Last Quarter Net Income | -52,150,000 | -30,730,000 | -7,510,000 | ||
| 60-Month Beta | 2.41 | 1.55 | N/A | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.31 on 03/05/25 | -0.29 on 03/27/25 | -0.21 on 03/20/25 | ||
| Latest Earnings Date | 05/08/25 | 05/05/25 | 05/14/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||